Surmodics reported $4.16M in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US $ 4423M 520M
Align Technology ALGN:US $ 260.75M 8.48M
Anika Therapeutics ANIK:US $ 16.51M 0.82M
Baxter International BAX:US $ 1883M 27M
Bioscrip BIOS:US $ 688.97M 27.66M
Boston Scientific BSX:US $ 914M 43M
Cryolife CRY:US $ 24.42M 1.22M
Edap Tms EDAP:US $ 5.82M 0.32M
Edwards Lifesciences EW:US $ 311.7M 22.6M
Genmark Diagnostics GNMK:US $ 30.68M 4.58M
Haemonetics HAE:US $ 117.15M 1.04M
Heron Therapeutics HRTX:US $ 11.35M 3.17M
Johnson & Johnson JNJ:US $ 7250M 317M
Merit Medical Systems MMSI:US $ 146.53M 9.66M
Mesa Laboratories MLAB:US $ 12.7M 0.01M
Nektar Therapeutics NKTR:US $ 5.31M 2.36M
Oxford Immunotec Global OXFD:US $ 4.58M 2.41M
Providence Service PRSC:US $ 399.27M 19.71M
Stryker SYK:US $ 1403M 179M
Surmodics SRDX:US $ 4.16M 0.95M
Trinity Biotech TRIB:US $ 14.82M 0.14M